Evidence map›Paper›PMID 35261997›Full record

ArticleJournal of clinical virology plus2021

Is there a role for SARS-CoV-2 antigen testing in the post-containment strategy?

Etienne Brochot

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical virology plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Etienne BrochotDepartment of Virology, Amiens University Medical Center, Amiens, France.
Centre Hospitalier Universitaire Amiens-Picardie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the availability and widespread deployment of antigenic tests for SARS-CoV-2 during the second epidemic wave in Europe, the performance of such tests in real-life situations is beginning to become available. Objectives: The question of the role of these tests during periods of low circulation of the virus has been legitimately raised. Study design: We addressed this question by analyzing the results of more than 16,000 SARS-CoV-2 PCRs during the first half of 2020 in a French region heavily affected by COVID-19. We were thus able to calculate and extrapolate the theoretical sensitivity of the antigenic tests for various periods during and after the first epidemic wave. Results: As the PCR-positivity rate of nasopharyngeal swabs declined over time, the proportion of samples with low Ct levels also decreased. Thus, the calculation of the analytical sensitivity of the antigenic tests ranged from 70 to 80% when the percentage of PCR positivity was > 1%, but fell below this score when it was lower. Conclusions: The performance and relevance of antigenic tests appears to be more limited during phases of low circulation of the virus. This may have a negative impact on the effectiveness of isolation, testing, and contact tracing strategies.

Indexed as

COVID-19PCR assaysPerformance assaysSARS-CoV-2

Identifiers

PMID35261997
PMCPMC7982323
OpenAlexW3136556144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.